$0.1450
-0.00500-3.33%
Pre-Market: Jan 16, 4:01 PM EDT
Comments
Loading...
PharmaTher Holdings Analyst Ratings and Price Targets | OTC:PHRRF | Benzinga
PharmaTher Holdings Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for PharmaTher Holdings Corp from these most-recent analyst ratings.
Analyst Ratings for PharmaTher Holdings
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for PharmaTher Holdings (PHRRF) stock?
There is no price target for PharmaTher Holdings
What is the most recent analyst rating for PharmaTher Holdings (PHRRF)?
There is no analyst for PharmaTher Holdings
When was the last upgrade for PharmaTher Holdings (PHRRF)?
There is no last upgrade for PharmaTher Holdings
When was the last downgrade for PharmaTher Holdings (PHRRF)?
There is no last downgrade for PharmaTher Holdings.
When is the next analyst rating going to be posted or updated for PharmaTher Holdings (PHRRF)?
There is no next analyst rating for PharmaTher Holdings.
Is the Analyst Rating PharmaTher Holdings (PHRRF) correct?
There is no next analyst rating for PharmaTher Holdings.
Browse analyst ratings and price targets on all stocks.